Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...

(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

What is RSV? RSV is a virus that comes with cold-like symptoms, like a runny nose, headache or sore throat. Symptoms are typically mild, but for some older adults, RSV can become very serious ...

Older adults and newborn babies are among those most at risk, leading to serious cases of pneumonia, a high number of ...

British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...

Vaccines for the Fall and Winter 2024–2025 season are now available. Generally, experts recommend COVID-19 and flu vaccines ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...